Clinical manifestations and treatments of Protobothrops mucrosquamatus bite and associated factors for wound necrosis and subsequent debridement and finger or toe amputation surgery

References

• Mao YC, Hung DZ. Epidemiology of snake envenomation in Taiwan. In: Gopalakrishnakone P, Faiz MA, Fernando R, et al., editors. Clinical toxinology in Asia Pacific and Africa. Singapore: Springer; 2015. p. 3–22.
   Google Scholar
• Mao YC, Hung DZ. Management of snake envenomation in Taiwan. In: Gopalakrishnakone P, Faiz MA, Fernando R, et al., editors. Clinical toxinology in Asia Pacific and Africa. Singapore: Springer; 2015. p. 23–52.
   Google Scholar
• Chen CK, Lin CC, Shih FY, et al. Population-based study of venomous snakebite in Taiwan. J Acute Med. 2015;5:38–42.
   Web of Science ®Google Scholar
• Uetz P, Freed P, Hošek J, et al. The Reptile Database. accessed 2020 Jan 19. Available from: http://wwwreptile-databaseorg/
   Google Scholar
• Vasaruchapong T, Laoungbua P, Tangrattanapibul K, et al. Protobothrops mucrosquamatus (Cantor, 1839), a highly venomous species added to the snake fauna of Thailand (Squamata: Viperidae). Trop Nat Hist. 2017;17:111–115.
   Google Scholar
• Chen YW, Chen MH, Chen YC, et al. Differences in clinical profiles of patients with Protobothrops mucrosquamatus and Viridovipera stejnegeri envenoming in Taiwan. Am J Trop Med Hyg. 2009;80:28–32.
   PubMed Web of Science ®Google Scholar
• Kuo TP, Wu CS. Clinico-pathological studies on snakebites in Taiwan. J Formos Med Assoc. 1972;71:447–466.
   Google Scholar
• Liao WB, Lee CW, Tsai YS, et al. Influential factors affecting prognosis of snakebite patients management: Kaohsiung Chang Gung Memorial Hospital experience. Chang Gung Med J. 2000;23:577–583.
   PubMedGoogle Scholar
• Su H, Li Y, Tang C, et al. Can surgery in patient with Protobothrops mucrosquamatus envenomation be predicted in emergency department? Hong Kong. J Emerg Med. 2016;23:210–219.
   Web of Science ®Google Scholar
• Blaylock R. Antibiotic use and infection in snakebite victims. S Afr Med J. 1999;89:874–876.
   PubMed Web of Science ®Google Scholar
• Tiwari A, Haq AI, Myint F, et al. Acute compartment syndromes. Br J Surg. 2002;89:397–412.
   PubMed Web of Science ®Google Scholar
• Guidelines for the management of snakebites. New Delhi: World Health Organization, Regional Office for South-East Asia. 2016.
   Google Scholar
• Mao YC, Liu PY, Chiang LC, et al. Naja atra snakebite in Taiwan. Clin Toxicol. 2018;56:273–280.
   PubMed Web of Science ®Google Scholar
• Mao YC, Liu PY, Hung DZ, et al. Bacteriology of Naja atra snakebite wound and its implications for antibiotic therapy. Am J Trop Med Hyg. 2016;94:1129–1135.
   PubMed Web of Science ®Google Scholar
• Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev. 2001;14:244–269.
   PubMed Web of Science ®Google Scholar
• World Health Organization guidelines for the production, control and regulation of snake antivenom immunoglobulins. Geneva: WHO; 2016.
   Google Scholar
• Hung DZ, Wu ML, Deng JF, et al. Russell’s viper snakebite in Taiwan: differences from other Asian countries. Toxicon. 2002;40:1291–1298.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Maduwage K, Scorgie FE, et al. Venom concentrations and clotting factor levels in a prospective cohort of Russell’s viper bites with coagulopathy. PLoS Negl Trop Dis. 2015;9:e0003968.
   PubMed Web of Science ®Google Scholar
• Williamson DR, Albert M, Heels-Ansdell D, et al. Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest. 2013;144:1207–1215.
   PubMed Web of Science ®Google Scholar
• Anagnostou K, Turner PJ. Myths, facts and controversies in the diagnosis and management of anaphylaxis. Arch Dis Child. 2019;104:83–90.
   PubMed Web of Science ®Google Scholar
• Ryan NM, Kearney RT, Brown SG, et al. Incidence of serum sickness after the administration of Australian snake antivenom (ASP-22). Clin Toxicol. 2016;54:27–33.
   PubMed Web of Science ®Google Scholar
• Nikai T, Mori N, Kishida M, et al. Isolation and characterization of hemorrhagic factors a and b from the venom of the Chinese habu snake (Trimeresurus mucrosquamatus). Biochim Biophys Acta. 1985;838:122–131.
   PubMed Web of Science ®Google Scholar
• Chiu HF, Chen J, Teng CM. Edema formation and degranulation of mast cells by a basic phospholipase A2 purified from Trimeresurus mucrosquamatus snake venom. Toxicon. 1989;27:115–125.
   PubMed Web of Science ®Google Scholar
• Wang JP, Peng HC, Teng CM. Rat hind-paw swelling effect of an edema-producing protein isolated from Trimeresurus mucrosquamatus snake venom. Naunyn Schmiedebergs Arch Pharmacol. 1991;343:399–404.
   PubMed Web of Science ®Google Scholar
• Wang JP, Teng CM. Roles of PMN leucocytes, platelets and some mediators in rat hind‐paw oedema induced by two phospholipase A2 enzymes from Trimeresurus mucrosquamatus venom. J Pharm Pharmacol. 1992;44:300–305.
   PubMed Web of Science ®Google Scholar
• Teng CM, Hsu MF, Wang JP. Comparison of kinin‐forming and amidolytic activities of four trimucases, oedema-producing and kinin-releasing enzymes, from Trimeresurus mucrosquamatus venom. J Pharm Pharmacol. 1992;44:306–310.
   PubMed Web of Science ®Google Scholar
• Wei JF, Wei Q, Lu QM, et al. Purification, characterization and biological activity of an L-amino acid oxidase from Trimeresurus mucrosquamatus venom. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao. 2003;35:219–224.
   PubMedGoogle Scholar
• Chen L, Liu CS, Chang CC. Isolation and characterization of a toxic phospholipase A2 from the venom of the Taiwan habu (Trimeresurus mucrosquamatus). Biotechnol Appl Biochem. 1994;19:61–73.
   PubMed Web of Science ®Google Scholar
• Wei JF, Li T, Wei XL, et al. Purification, characterization and cytokine release function of a novel Arg-49 phospholipase A2 from the venom of Protobothrops mucrosquamatus. Biochimie. 2006;88:1331–1342.
   PubMed Web of Science ®Google Scholar
• Wei JF, Wei X, Chen QY, et al. N49 phospholipase A2, a unique subgroup of snake venom group II phospholipase A2. Biochim Biophys Acta. 2006;1760:462–471.
   PubMed Web of Science ®Google Scholar
• Rojnuckarin P, Mahasandana S, Intragumthornchai T, et al. Prognostic factors of green pit viper bites. Am J Trop Med Hyg. 1998;58:22–25.
   PubMed Web of Science ®Google Scholar
• Lin CC, Wang PJ, Liu CC. Venom concentrations in blisters and hemorrhagic bullae in a patient bitten by a Taiwan habu (Protobothrops mucrosquamatus). Rev Soc Bras Med Trop. 2019;52:e20180160.
   PubMed Web of Science ®Google Scholar
• Ribeiro LA, Jorge MT, Lebrao ML. Prognostic factors for local necrosis in Bothrops jararaca (Brazilian pit viper) bites. Trans R Soc Trop Med Hyg. 2001;95:630–634.
   PubMed Web of Science ®Google Scholar
• Gnaneswaran N, Perera E, Perera M, et al. Cutaneous chemical burns: assessment and early management. Aust Fam Physician. 2015;44:135–139.
   PubMedGoogle Scholar
• Jiménez N, Escalante T, Gutiérrez JM, et al. Skin pathology induced by snake venom metalloproteinase: acute damage, revascularization, and re-epithelization in a mouse ear model. J Inves Dermatol. 2008;128:2421–2428.
   PubMed Web of Science ®Google Scholar
• Chen CM, Wu KG, Chen CJ, et al. Bacterial infection in association with snakebite: a 10-year experience in a northern Taiwan medical center. J Microbiol Immunol Infect. 2011;44:456–460.
   PubMedGoogle Scholar
• Pfaller M, Diekema D, Gibbs D, et al.; the Global Antifungal Surveillance Group. Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005. J Clin Microbiol. 2008;46:842–849.
   PubMed Web of Science ®Google Scholar
• Gardner SE, Frantz RA, Doebbeling BN. The validity of the clinical signs and symptoms used to identify localized chronic wound infection. Wound Repair Regen. 2001;9:178–186.
   PubMed Web of Science ®Google Scholar
• August JA, Boesen KJ, Hurst NB, et al. Prophylactic antibiotics are not needed following rattlesnake bites. Am J Med. 2018;131:1367–1371.
   PubMed Web of Science ®Google Scholar
• LoVecchio F, Klemens J, Welch S, et al. Antibiotics after rattlesnake envenomation. J Emerg Med. 2002;23:327–328.
   PubMed Web of Science ®Google Scholar
• Talan DA, Citron DM, Overturf GD, et al. Antibacterial activity of crotalid venoms against oral snake flora and other clinical bacteria. J Infect Dis. 1991;164:195–198.
   PubMed Web of Science ®Google Scholar
• Sala A, Cabassi CS, Santospirito D, et al. Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity. PLoS One. 2018;13:e0190778.
   PubMed Web of Science ®Google Scholar
• Hsu CP, Chuang JF, Hsu YP, et al. Predictors of the development of post-snakebite compartment syndrome. Scand J Trauma Resusc Emerg Med. 2015;23:97–103.
   PubMed Web of Science ®Google Scholar
• Hsieh YH, Hsueh JH, Liu WC, et al. Contributing factors for complications and outcomes in patients with snakebite: experience in a medical center in southern Taiwan. Ann Plast Surg. 2017;78:S32–S36.
   PubMed Web of Science ®Google Scholar
• Ho CH, Mao YC, Tsai YD, et al. Descriptive study of snakebite patients in northern Taiwan: 2009 to 2016. J Med Sci. 2019;39:114–120.
   Google Scholar
• McQueen MM, Duckworth AD, Aitken SA, et al. The estimated sensitivity and specificity of compartment pressure monitoring for acute compartment syndrome. J Bone Joint Surg Am. 2013;95:673–677.
   PubMed Web of Science ®Google Scholar
• Villalta M, Pla D, Yang SL, et al. Snake venomics and antivenomics of Protobothrops mucrosquamatus and Viridovipera stejnegeri from Taiwan: keys to understand the variable immune response in horses. J Proteomics. 2012;75:5628–5645.
   PubMed Web of Science ®Google Scholar
• Kishida M, Nikai T, Mori N, et al. Characterization of mucrotoxin A from the venom of Trimeresurus mucrosquamatus (the Chinese habu snake). Toxicon. 1985;23:637–645.
   PubMed Web of Science ®Google Scholar
• Tsai IH, Lu PJ, Wang YM, et al. Molecular cloning and characterization of a neurotoxic phospholipase A2 from the venom of Taiwan habu (Trimeresurus mucrosquamatus). Biochem J. 1995;311:895–900.
   PubMed Web of Science ®Google Scholar
• Huang K, Hung C, Chiou SH. Characterization of three fibrinogenolytic proteases isolated from the venom of Taiwan habu (Trimeresurus mucrosquamatus). Biochem. Mol. Biol. Int. 1993;31:1041–1050.
   PubMedGoogle Scholar
• Ouyang C, Teng CM, Huang TF. Characterization of the purified principles of Formosan snake venoms which affect blood coagulation and platelet aggregation. J Formos Med Assoc. 1982;81:781–790.
   Google Scholar
• Ouyang C, Teng CM, Chen YC. Properties of fibrinogen degradation products produced by α-and β-fibrinogenases of Trimeresurus mucrosquamatus snake venom. Toxicon. 1979;17:121–126.
   PubMed Web of Science ®Google Scholar
• Hung CC, Chiou SH. Fibrinogenolytic proteases isolated from the snake venom of Taiwan habu: serine proteases with kallikrein-like and angiotensin-degrading activities. Biochem Biophys Res Commun. 2001;281:1012–1018.
   PubMed Web of Science ®Google Scholar
• Tsai IH, Wang YM, Lee YH. Characterization of a cDNA encoding the precursor of platelet aggregation inhibitor and metallproteinase from Trimeresurus mucrosquamatus venom. Biochim Biophys Acta. 1994;1200:337–340.
   PubMed Web of Science ®Google Scholar
• Debono J, Bos MH, Nouwens A, et al. Habu coagulotoxicity: clinical implications of the functional diversification of Protobothrops snake venoms upon blood clotting factors. Toxicol In Vitro. 2019;55:62–74.
   PubMed Web of Science ®Google Scholar
• Hung CC, Huang KF, Chiou SH. Characterization of one novel venom protease with β-Fibrinogenase activity from the Taiwan habu (Trimeresurus mucrosquamatus): purification and cDNA sequence analysis. Biochem Biophys Res Commun. 1994;205:1707–1715.
   PubMed Web of Science ®Google Scholar
• Ho C, Teng C, Lee C. Presynaptic and musculotropic effects of a basic phospholipase A2 from the Formosan habu (Trimeresurus mucrosquamatus) venom. Toxicon. 1984;22:813–816.
   PubMed Web of Science ®Google Scholar
• Ullah A, Souza T, Zanphorlin L, et al. Crystal structure of jararacussin‐I: the highly negatively charged catalytic interface contributes to macromolecular selectivity in snake venom thrombin‐like enzymes. Protein Sci. 2013;22:128–132.
   PubMed Web of Science ®Google Scholar
• Lu Q, Navdaev A, Clemetson JM, et al. GPIb is involved in platelet aggregation induced by mucetin, a snake C-type lectin protein from Chinese habu (Trimeresurus mucrosquamatus) venom. Thromb Haemost. 2004;91:1168–1176.
   PubMed Web of Science ®Google Scholar
• Ouyang C, Wang JP, Teng CM. A potent platelet aggregation inducer purified from Trimeresurus mucrosquamatus snake venom. Biochim Biophys Acta. 1980;630:246–253.
   PubMed Web of Science ®Google Scholar
• Huang KF, Chow LP, Chiou SH. Isolation and characterization of a novel proteinase inhibitor from the snake serum of Taiwan habu (Trimeresurus mucrosquamatus). Biochem Biophys Res Commun. 1999;263:610–616.
   PubMed Web of Science ®Google Scholar
• Sugihara H, Nikai T, Naruse M, et al. Purification and characterization of phosphodiesterase from the venom of Trimeresurus mucrosquamatus. Int J Biochem. 1986;18:203–207.
   PubMedGoogle Scholar
• Rucavado A, Soto M, Escalante T, et al. Thrombocytopenia and platelet hypoaggregation induced by Bothrops asper snake venom. Thromb Haemost. 2005;94:123–131.
   PubMed Web of Science ®Google Scholar
• Herrera C, Rucavado A, Warrell DA, et al. Systemic effects induced by the venom of the snake Bothrops caribbaeus in a murine model. Toxicon. 2013;63:19–31.
   PubMed Web of Science ®Google Scholar
• Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009;361:62–72.
   PubMed Web of Science ®Google Scholar
• Hung DZ, Wu ML, Deng JF, et al. Multiple thrombotic occlusions of vessels after Russell’s viper envenoming. Pharmacol Toxicol. 2002;91:106–110.
   PubMedGoogle Scholar